§ Mr. Ashleyasked the Secretary of State for Social Services (1) what requests were made to his Department about licensing the medical drug Amrinone; what replies he sent; and if he will make a statement;
(2) what requests his Department received about a clinical trials certificate with oral Amrinone; what reply was sent; and if he will make a statement;
(3) what trials have been conducted in National Health Service hospitals with the medical drug Amrinone; how many patients suffered serious side effects; and if he will make a statement;
(4) on how many occasions Dr. Wilmshurst requested his Department to investigate the pharmaceutical company Sterling-Winthrop under the Medicines Act 1968, for its actions on Amrinone; what replies he sent; and if he will make a statement;
(5) if he will publish the evidence received in the course of his inquiries into the activities of the pharmaceutical company Sterling-Winthrop regarding its activities with the medical drug Amrinone; and if he will make a statement;
(6) if he will hold an immediate inquiry into the pharmaceutical firm Sterling-Winthrop in respect of its activities relating to the medical drug Amrinone;
(7) what adverse reactions from the medical drug Amrinone were reported to his Department; and if he will investigate the interpretation of the data provided by Sterling-Winthrop.
§ Mrs. CurrieI shall let the right hon. Member have replies as soon as possible.